Gross Profit: Revenues from operations less the associated costs.
Arcus Biosciences, Inc. (RCUS) had Gross Profit of $17.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$17.00M |
|
$-128.00M |
|
-- |
|
|
Gross Profit |
$17.00M |
$151.00M |
|
$-134.00M |
|
$6.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-128.00M |
|
$-134.00M |
|
$-135.00M |
|
125.40M |
|
125.40M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$844.00M |
|
$38.00M |
|
$153.00M |
|
$997.00M |
|
$209.00M |
|
$100.00M |
|
$264.00M |
|
$473.00M |
|
$524.00M |
|
$524.00M |
|
$524.00M |
|
125.50M |
|
| Cash Flow Statement Financials | |
$-138.00M |
|
$114.00M |
|
$3.00M |
|
$225.00M |
|
$204.00M |
|
$-21.00M |
|
$19.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.04 |
|
-- |
|
-- |
|
0.16 |
|
0.19 |
|
100.00% |
|
-788.24% |
|
-788.24% |
|
-- |
|
-752.94% |
|
-752.94% |
|
$-138.00M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
5.67 |
|
15.88 |
|
-24.43% |
|
-24.43% |
|
-12.84% |
|
-20.51% |
|
$4.18 |
|
$-1.10 |
|
$-1.10 |
|